Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Atria Venturesatria.vc · Low evidenceAtria Ventures is a solo-capitalist life sciences venture firm that makes initial investments of $250K to $1M in first funding rounds. It partners with founders building computational biology platforms, AI infrastructure, and vertical life sciences software, helping unlock business development, licensing, and distribution channels. Led by Chris Leiter since 2023, the portfolio includes Abridge, Axiom, Evolv, HairDAO, HOX, Lighten, Molecule, Orchestra, Peer, Resync (acquired by Benchling), Sleuth, Specie Bio, Tandem, Trially, and several stealth programs.
Parse Score